[Genetic techniques in drug production. Current status and future perspectives. 2: Approved recombinant substances].
Hentze
S
S
D004921:Erythropoietin / Q000627:therapeutic use; D005544:Forecasting; D005821:Genetic Techniques / Q000639:trends*; D013006:Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D007328:Insulin; D011994:Recombinant Proteins; D004921:Erythropoietin; D013006:Growth Hormone; D007372:Interferons; D010959:Tissue Plasminogen Activator
Gentechnisch gewonnene Arzneimittel. Heutiger Stand und Zukunftsperspektiven. Folge 2: Zugelassene rekombinante Präparate.